Researcher
Steven De Vleeschouwer
- Disciplines:Biomechanics, Morphological sciences, Neurosciences, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Responsible
From1 Jan 2013 → Today - Research Group Experimental Neurosurgery and Neuroanatomy (Division)
Member
From1 Aug 2001 → Today
Projects
1 - 10 of 22
- Molecular Brain Tumor DetectorFrom1 Feb 2024 → TodayFunding: Other EU initiatives out of framework
- The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomicsFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- Immunotherapy for childhood, adolescent, and adult Glioblastoma: towards tumour-immune interactions driven precision medicine using spatially resolved radio-multiomics.From15 Jan 2023 → TodayFunding: BOF - various
- Investigating the role of astrocytes and noradrenaline as critical regulators of neuronal circuit excitability.From1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- De evidentie rond het coiling-clipping paradigma in de behandeling van cerebrale aneurysmata uitdagen en in kaart brengen door middel van multimodale stratificatie.From8 Dec 2021 → TodayFunding: FWO Strategic Basic Research Grant
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Evaluating the Role of Autophagy in the Tumor Vasculature and as Anti-angiogenic Escape MechanismFrom1 Oct 2020 → 30 Sep 2021Funding: BOF - postdoctoral mandates
- Opening the brain blood barrier to treat brain tumoursFrom1 Jan 2020 → 31 Dec 2022Funding: H2020 - European Institute of Innovation and Technology, Horizon Europe - European Institute of Innovation and Technology (EIT)
- Screening of Hyp-PDT induced ICD-sensitive GBM Immunophenotype and Exploration of Synergetic Effect of Sonodynamic Therapy in GBM ImmunotherapyFrom2 Dec 2019 → 2 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Visual prostheses based on high resolution brain stimulationFrom1 Oct 2019 → 30 Sep 2023Funding: BOF - projects
Publications
21 - 30 of 141
- Integrating hyperspectral imaging in an existing intra-operative environment for detection of intrinsic brain tumors(2023)
Authors: Lien Solie, Steven De Vleeschouwer
Number of pages: 10 - Trial watch: Dendritic cell (DC)-based immunotherapy for cancer(2022)
Authors: Jenny Sprooten, Stefan Naulaerts, Benoit Beuselinck, An Coosemans, Lisa Kinget, Sandra Tuyaerts, Steven De Vleeschouwer, Abhishek Garg
- The diagnostic accuracy of intraoperative differentiation and delineation techniques in brain tumours(2022)
Authors: Steven De Vleeschouwer, Tom Theys, Steffen Rex, Eva Cuypers
- A MULTI-OMIC, FUNCTIONAL PRECISION ONCOLOGY METHOD TO IDENTIFY RESPONSIVE GLIOBLASTOMA TUMOR CELLS AT SINGLE CELL RESOLUTION(2022)
Authors: Yanti De Visser, Dena Panovska, Steven De Vleeschouwer, Lien Solie, Paul Clement, Raf Sciot, Frederik De Smet
Pages: 7 - 7 - GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide(2022)
Authors: Steven De Vleeschouwer, Raf Sciot, Jenny Weng, Francesca Bosisio, Gabriele Bergers, Frederik De Smet, Diether Lambrechts, Sarah-Maria Fendt
- Safe surgery for glioblastoma: Recent advances and modern challenges(2022)
Authors: Steven De Vleeschouwer
Pages: 364 - 379 - The "Yin and Yang" of Unfolded Protein Response in Cancer and Immunogenic Cell Death(2022)
Authors: Steven De Vleeschouwer, Patrizia Agostinis
- The PROGRAM study: awake mapping versus asleep mapping versus no mapping for high-grade glioma resections: study protocol for an international multicenter prospective three-arm cohort study (vol 11, e047306, 2021)(2022)
Authors: Steven De Vleeschouwer
- Exploring stem cell biology in pituitary tumors and derived organoids(2022)
Authors: Charlotte Nys, Ellen De Pauw, Raf Sciot, Steven De Vleeschouwer, Johan van Loon, Hugo Vankelecom
Pages: 427 - 450 - Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study(2022)
Authors: Lien Solie, Steven De Vleeschouwer
Pages: 802 - 817
Patents
1 - 3 of 3
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)
- Treatment of central nervous tumours (Inventor)